investor icfi.com

Investor Overview ICFi Investor Relations

ICF International, a global professional services firm, is listed on the NASDAQ Global Select Market under the symbol ICFI.

OVERVIEW

This site investor.icfi.com presently has an average traffic classification of zero (the lower the better). There is five mass web accounts belong to this website.
Social Links
5

INVESTOR.ICFI.COM RANKINGS

This site investor.icfi.com is seeing alternating levels of traffic all over the year.
Traffic for investor.icfi.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for investor.icfi.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for investor.icfi.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES INVESTOR.ICFI.COM LOOK LIKE?

Desktop Screenshot of investor.icfi.com Mobile Screenshot of investor.icfi.com Tablet Screenshot of investor.icfi.com

INVESTOR.ICFI.COM HOST

We caught that a single root page on investor.icfi.com took zero milliseconds to come up. We could not find a SSL certificate, so therefore our crawlers consider investor.icfi.com not secure.
Load time
0 secs
SSL
NOT SECURE
Internet Protocol
23.55.218.214

BROWSER ICON

PAGE TITLE

Investor Overview ICFi Investor Relations

DESCRIPTION

ICF International, a global professional services firm, is listed on the NASDAQ Global Select Market under the symbol ICFI.

CONTENT

This site states the following, "Strategy, Policy Analysis, Regulatory Development." We noticed that the web page also stated " ICF in Africa the Middle East." It also stated " ICF in Asia the Pacific. ICF International NASDAQICFI provides professional services and technology solutions that deliver beneficial impact in areas critical to the worlds future. ICF is fluent in the language of change, whether driven by markets, technology, or policy. Data as of 080715 400 pm ET."

SEEK MORE WEB PAGES

ICON - Investors - ICON plc - Investor Relations

Lower-cost transactional solutions with strategic resourcing and innovative technologies. Integrated services that cover planning, management, execution and analysis. Insight on strategies and execution for long-term value to maximise success. Global experience in all Phases of oncology drug development. Offering solutions that combine in-house expertise and proprietary innovative technology. 2 - 5 April, 2018.

Illumina . Investor Relations Overview

Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe. Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market. Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015. Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics. Q2 2015 Illumina, Inc.

Investor Relations Immucor, Inc. IR Site

Vision, Mission and Values. Our mission is to ensure that patients in need of blood, organs, or stem cells get the right match that is safe, accessible, and affordable. Avi Pelossof Appointed President and CEO of Immucor.

Investors ImmunoGen, Inc.

What is an ADC? What is an ADC? And in programs in development by Amgen, Bayer, Biotest, CytomX, Debiopharm, Lilly, Novartis, Sanofi and Takeda. More information about the Company can be found at www. ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Society of Gynecologic Oncology Annual Meeting. There are no items to display.

inContact Investor Relations Investor Relations

InContact Reports Second Quarter 2015 Financial Results. InContact CEO Paul Jarman and CFO Greg Ayers to Present at the Oppenheimer 18th Annual Technology, Internet and Communications Conference. InContact Sets Second Quarter 2015 Conference Call. International Business Process Outsourcer Expands Existing inContact Solution with Workforce Management in the Cloud.